Ishak Maycel, Ali Danish, Fokkert Marion J, Slingerland Robbert J, Dikkeschei Bert, Tolsma Rudolf T, Lichtveld Rob A, Bruins Wendy, Boomars René, Bruheim Kim, van Eenennaam Fred, Timmers Leo, Voskuil Michiel, Doevendans Pieter A, Mosterd Arend, Hoes Arno W, ten Berg Jurriën M, van 't Hof Arnoud W J
Department of Cardiology, St. Antonius Hospital Nieuwegein, The Netherlands Division Heart and Lungs, Department of Cardiology, University Medical Center Utrecht, The Netherlands.
Department of Cardiology, Isala Zwolle, The Netherlands.
Eur Heart J Acute Cardiovasc Care. 2015 Apr;4(2):129-36. doi: 10.1177/2048872614549738. Epub 2014 Sep 8.
For chest pain patients without ST-segment elevation in the pre-hospital setting, current clinical guidelines merely offer in-hospital risk stratification and management, as opposed to chest pain patients with ST-segment elevation for whom there is a straightforward pre-hospital strategy for diagnosis, medication regimen and logistics. The FAMOUS TRIAGE study will assess the effects of introducing a pre-hospital triage system that reliably stratifies chest pain patients without ST-segment elevation into 1) patients at high risk for NSTEMI requiring a direct transfer to a PCI-hospital; 2) patients at intermediate risk for a major adverse cardiac event (MACE) who could be evaluated at the nearest non-PCI hospital; and 3) patients at low risk for MACE (benign non-cardiac chest pain) who could have further evaluation at home or in a primary care setting.
The FAMOUS TRIAGE study will be performed in three phases. In the first phase an appropriate pre-hospital risk stratification tool will be designed for chest pain patients without ST-segment elevation by means of a retrospective and a prospective study. The second phase of the project represents the external validation of the risk stratification models, and in the third and final phase an optimal risk stratification tool will be implemented into clinical practice. Clinical and economical endpoints before and after implementation of the pre-hospital risk stratification tool will be compared to assess clinical benefit and cost-effectiveness.
The FAMOUS TRIAGE project is a triple phase study that aims to optimize the pre-hospital management of chest pain patients without ST-segment elevation by providing tools for pre-hospital identification of NSTEMI or exclusion of acute coronary syndrome at home.
NTR4205. Dutch Trial Register [http://www.trialregister.nl]: trial number 4205.
对于院前环境下无ST段抬高的胸痛患者,当前临床指南仅提供院内风险分层和管理,这与有ST段抬高的胸痛患者不同,后者有直接的院前诊断策略、药物治疗方案和后勤安排。FAMOUS TRIAGE研究将评估引入一种院前分诊系统的效果,该系统能可靠地将无ST段抬高的胸痛患者分层为:1)非ST段抬高型心肌梗死(NSTEMI)高危患者,需要直接转至可进行经皮冠状动脉介入治疗(PCI)的医院;2)发生重大不良心脏事件(MACE)中危患者,可在最近的非PCI医院进行评估;3)MACE低危患者(良性非心脏性胸痛),可在家中或基层医疗环境中进行进一步评估。
FAMOUS TRIAGE研究将分三个阶段进行。第一阶段,通过回顾性和前瞻性研究,为无ST段抬高的胸痛患者设计一种合适的院前风险分层工具。项目的第二阶段是对风险分层模型进行外部验证,在第三阶段也是最后阶段,将一种最佳风险分层工具应用于临床实践。比较院前风险分层工具实施前后的临床和经济终点,以评估临床获益和成本效益。
FAMOUS TRIAGE项目是一项三阶段研究,旨在通过提供院前识别NSTEMI或在家中排除急性冠状动脉综合征的工具,优化无ST段抬高的胸痛患者的院前管理。
NTR4205。荷兰试验注册中心[http://www.trialregister.nl]:试验编号4205。